To elaborate on the downstream target of miR-542-3p in bladder cancer, we searched StarBase database, TargetScan database and miRDB database, and 108 potential genes were predicted to have the complementary binding sites with miR-542-3p, and ILK was among the candidate targets (Figure 5A, 5B). This evidence concerns the gene ILK and urinary bladder cancer.